Fluvoxamine for symptomatic outpatients with COVID-19

CMAJ. 2022 Feb 22;194(7):E258. doi: 10.1503/cmaj.220011. Epub 2022 Jan 19.

¹ Division of General Internal Medicine and Geriatrics (Wu), University Health Network; Division of Clinical Pharmacology and Toxicology (Wu), Department of Medicine, University of Toronto; Division of Emergency Medicine (Austin), St. Michael's Hospital; Ontario Poison Centre (Austin), Hospital for Sick Children; Department of Pharmacy (Leong), University Health Network, Toronto, Ont. peter.wu@uhn.ca.
² Division of General Internal Medicine and Geriatrics (Wu), University Health Network; Division of Clinical Pharmacology and Toxicology (Wu), Department of Medicine, University of Toronto; Division of Emergency Medicine (Austin), St. Michael's Hospital; Ontario Poison Centre (Austin), Hospital for Sick Children; Department of Pharmacy (Leong), University Health Network, Toronto, Ont.

No abstract available

Publication types